SEARCH

SEARCH BY CITATION

References

  • Alam J. and Smith A. (1989) Receptor-mediated transport of heme by hemopexin regulates gene expression in mammalian cells. J. Biol. Chem. 264, 1763717640.
  • Alam J., Stewart D., Touchard C., Boinapally S., Choi A. M. and Cook J. L. (1999) Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J. Biol. Chem. 274, 2607126078.
  • Bandyopadhyay S., Ni J., Ruggiero A., Walshe K., Rogers M. S., Chattopadhyay N., Glicksman M. A. and Rogers J. T. (2006) A high-throughput drug screen targeted to the 5'untranslated region of Alzheimer amyloid precursor protein mRNA. J. Biomol. Screen. 11, 469480.
  • Bartzokis G., Sultzer D., Cummings J., Holt L. E., Hance D. B., Henderson V. W. and Mintz J. (2000) In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging. Arch. Gen. Psychiatry 57, 4753.
  • Beaven G. H., Chen S.-H., D'Albis A. and Gratzer W. B. (1974) A spectroscopic study of the haemin-human-serum-albumin system. Eur. J. Biochem. 41, 539546.
  • Brenner S. R. (2008) Neurovascular unit dysfunction: a vascular component of Alzheimer disease? Neurology 70, 243244.
  • Buehler P. W., Abraham B., Vallelian F. et al. (2009) Haptoglobin preserves the CD163 hemoglobin scavenger pathway by shielding hemoglobin from peroxidative modification. Blood 113, 25782586.
  • Chen J. and Regan R. F. (2004) Heme oxygenase-2 gene deletion increases astrocyte vulnerability to hemin. Biochem. Biophys. Res. Commun. 318, 8894.
  • Chen L., Zhang X., Chen-Roetling J. and Regan R. F. (2010) Increased striatal injury and behavioral deficits after intracerebral hemorrhage in hemopexin knockout mice. J. Neurosurg. 114, 11591167.
  • Cho H. H., Cahill C. M., Vanderburg C. R., Scherzer C. R., Wang B., Huang X. and Rogers J. T. (2010) Selective translational control of the Alzheimer amyloid precursor protein transcript by iron regulatory protein-1. J. Biol. Chem. 285, 3121731232.
  • Cordonnier C. and van der Flier W. M. (2011) Brain microbleeds and Alzheimer's disease: innocent observation or key player? Brain 134, 335344.
  • Crapper McLachlan D. R., Dalton A. J., Kruck T. P., Bell M. Y., Smith W. L., Kalow W. and Andrews D. F. (1991) Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet 337, 13041308.
  • Davies D. M., Smith A., Muller-Eberhard U. and Morgan W. T. (1979) Hepatic subcellular metabolism of heme from heme-hemopexin: incorporation of iron into ferritin. Biochem. Biophys. Res. Commun. 91, 15041511.
  • Duce J. A., Tsatsanis A., Cater M. A. et al. (2010) Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell 142, 857867.
  • Eskew J. D., Vanacore R. M., Sung L., Morales P. J. and Smith A. (1999) Cellular protection mechanisms against extracellular heme: heme- hemopexin, but not free heme, activates the N-terminal c-Jun kinase. J. Biol. Chem. 274, 638648.
  • Figueiredo R. T., Fernandez P. L., Mourao-Sa D. S., Porto B. N., Dutra F. F., Alves L. S., Oliveira M. F., Oliveira P. L., Graca-Souza A. V. and Bozza M. T. (2007) Characterization of heme as activator of Toll-like receptor 4. J. Biol. Chem. 282, 2022120229.
  • Flaherty M. M., Rish K. R., Smith A. and Crumbliss A. L. (2008) An investigation of hemopexin redox properties by spectroelectrochemistry: biological relevance for heme uptake. Biometals 21, 239248.
  • Fliss H. (1988) Oxidation of proteins in rat heart and lungs by polymorphonuclear leukocyte oxidants. Mol. Cell. Biochem. 84, 177188.
  • Gebicka L. and Banasiak E. (2012) Hypochlorous acid-induced heme damage of hemoglobin and its inhibition by flavonoids. Toxicol. In Vitro 26, 924929.
  • Gottlieb Y., Truman M., Cohen L. A., Leichtmann-Bardoogo Y. and Meyron-Holtz E. G. (2012) Endoplasmic reticulum anchored heme-oxygenase-1 faces the cytosol. Haematologica 97, 14891493.
  • Grinberg L. N., O'Brien P. J. and Hrkal Z. (1999) The effects of heme-binding proteins on the peroxidative and catalatic activities of hemin. Free Radic. Biol. Med. 27, 214219.
  • Guo Y., Schneider L. A. and Wangensteen O. D. (1995) HOCl effects on tracheal epithelium: conductance and permeability measurements. J. Appl. Physiol. 78, 13301338.
  • Gupta S., Ahern K., Nakhl F. and Forte F. (2011) Clinical usefulness of haptoglobin levels to evaluate hemolysis in recently transfused patients. Adv. Hematol. 2011, 389854.
  • Gutteridge J. M. and Smith A. (1988) Antioxidant protection by haemopexin of haem-stimulated lipid peroxidation. Biochem. J. 256, 861865.
  • Hershko C. (2007) Mechanism of iron toxicity. Food Nutr. Bull. 28, S500S509.
  • Hrkal Z., Vodrazka Z. and Kalousek I. (1974) Transfer of heme from ferrihemoglobin and ferrihemoglobin isolated chains to hemopexin. Eur. J. Biochem. 43, 7378.
  • Hunt R. C., Handy I. and Smith A. (1996a) Haem exacerbates reactive oxygen species toxicity to human retinal pigment epithelial cells while the haem-binding protein, haemopexin, is protective. J. Cell. Physiol. 168, 8186.
  • Hunt R. C., Hunt D. M., Gaur N. and Smith A. (1996b) Hemopexin in the human retina: protection of the retina against heme- mediated toxicity. J. Cell. Physiol. 168, 7180.
  • Hunter M. J. and McDuffie F. C. (1959) Molecular weight studies on human serum albumin after reduction and alkylation of disulfide bonds. J. Am. Chem. Soc. 81, 14001406.
  • Jiang Z.-Y., Woollard A. C. S. and Wolff S. P. (1990) Hydrogen peroxide production during experimental protein glycation. FEBS Lett. 268, 6971.
  • Kettle A. J. and Winterbourn C. C. (1994) Assays for the chlorination activity of myeloperoxidase. Methods Enzymol. 233, 502512.
  • Larsen R., Gozzelino R., Jeney V. et al. (2010) A central role for free heme in the pathogenesis of severe sepsis. Sci. Transl. Med. 2, 51ra71.
  • Li R. C., Saleem S., Zhen G., Cao W., Zhuang H., Lee J., Smith A., Altruda F., Tolosano E. and Dore S. (2009) Heme-hemopexin complex attenuates neuronal cell death and stroke damage. J. Cereb. Blood Flow Metab. 29, 953964.
  • Li B., Takeda K., Ishikawa K., Yoshizawa M., Sato M., Shibahara S. and Furuyama K. (2012) Coordinated expression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 and heme oxygenase 2: evidence for a regulatory link between glycolysis and heme catabolism. Tohoku J. Exp. Med. 228, 2741.
  • Liang X., Lin T., Sun G., Beasley-Topliffe L., Cavaillon J. M. and Warren H. S. (2009) Hemopexin down-regulates LPS-induced proinflammatory cytokines from macrophages. J. Leukoc. Biol. 86, 229235.
  • Lin Q., Weis S., Yang G. et al. (2007) Heme oxygenase-1 protein localizes to the nucleus and activates transcription factors important in oxidative stress. J. Biol. Chem. 282, 2062120633.
  • Lin T., Sammy F., Yang H., Thundivalappil S., Hellman J., Tracey K. J. and Warren H. S. (2012) Identification of hemopexin as an anti-inflammatory factor that inhibits synergy of hemoglobin with HMGB1 in sterile and infectious inflammation. J. Immunol. 189, 20172022.
  • Liu X. and Zweier J. L. (2001) A real-time electrochemical technique for measurement of cellular hydrogen peroxide generation and consumption: evaluation in human polymorphonuclear leukocytes. Free Radic. Biol. Med. 31, 894901.
  • McCall M. R., Carr A. C., Forte T. M. and Frei B. (2001) Ldl modified by hypochlorous acid is a potent inhibitor of lecithin-cholesterol acyltransferase activity. Arterioscler. Thromb. Vasc. Biol. 21, 10401045.
  • McColl B. W., Rothwell N. J. and Allan S. M. (2008) Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. J. Neurosci. 28, 94519462.
  • Morgan W. T. and Muller-Eberhard U. (1972) Interactions of porphyrins with rabbit hemopexin. J. Biol. Chem. 247, 71817187.
  • Morgan W. and Smith A. (2001). Binding and transport of iron-porphyrins by hemopexin, in Advances in Inorganic Chemistry (Mauk G. and Sykes A. G.,eds), pp. 205241. Academic Press, London, UK & San Diego, CA, USA.
  • Morgan W. T., Liem H. H., Sutor R. P. and Muller-Ebergard U. (1976) Transfer of heme from heme-albumin to hemopexin. Biochim. Biophys. Acta 444, 435445.
  • Morris J. C. (1966). The Acid Ionization Constant of HOCl from 5 to 35°. J. Phys. Chem. 70, 37983805.
  • Morse D. and Choi A. M. (2002) Heme oxygenase-1: the “emerging molecule” has arrived. Am. J. Respir. Cell Mol. Biol. 27, 816.
  • Otterbein L. E., Hedblom A., Harris C., Csizmadia E., Gallo D. and Wegiel B. (2011) Heme oxygenase-1 and carbon monoxide modulate DNA repair through ataxia-telangiectasia mutated (ATM) protein. Proc. Natl Acad. Sci. USA 108, 1449114496.
  • Pasternack R. F., Gibbs E. J., Hoeflin E., Kosar W. P., Kubera G., Skowronek C. A., Wong N. M. and Muller-Eberhard U. (1983) Hemin binding to serum proteins and the catalysis of interprotein transfer. Biochemistry 22, 17531758.
  • Qureshi A. I., Tuhrim S., Broderick J. P., Batjer H. H., Hondo H. and Hanley D. F. (2001) Spontaneous intracerebral hemorrhage. N. Engl. J. Med. 344, 14501460.
  • Reiter C. D., Wang X., Tanus-Santos J. E., Hogg N., Cannon R. O. III, Schechter A. N. and Gladwin M. T. (2002) Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat. Med. 8, 13831389.
  • Rish K. R., Swartzlander R., Sadikot T. N., Berridge M. V. and Smith A. (2007) Evidence that heme and heme-hemopexin interact with cell growth-associated plasma membrane electron transport. Biochem. Biophys. Acta Bioenerg. 1767, 11071117.
  • Rogers J. T., Randall J. D., Cahill C. M. et al. (2002) An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript. J. Biol. Chem. 277, 4551845528.
  • Schipper H. M. (2004) Heme oxygenase-1: transducer of pathological brain iron sequestration under oxidative stress. Ann. N. Y. Acad. Sci. 1012, 8493.
  • Schipper H. M., Gupta A. and Szarek W. A. (2009a) Suppression of glial HO-1 activity as a potential neurotherapeutic intervention in AD. Curr. Alzheimer Res. 6, 424430.
  • Schipper H. M., Song W., Zukor H., Hascalovici J. R. and Zeligman D. (2009b) Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement. J. Neurochem. 110, 469485.
  • Schobel S., Neumann S., Seed B. and Lichtenthaler S. F. (2006) Expression cloning screen for modifiers of amyloid precursor protein shedding. Int. J. Dev. Neurosci. 24, 141148.
  • Schroder E. and Eaton P. (2008) Hydrogen peroxide as an endogenous mediator and exogenous tool in cardiovascular research: issues and considerations. Curr. Opin. Pharmacol. 8, 153159.
  • Siesjo B. K., Katsura K. and Kristian T. (1996) Acidosis-related damage. Adv. Neurol. 71, 209236.
  • Smith A. (2011). Mechanisms of Cytoprotection by Hemopexin, in Handbook of Porphyrin Science. Biochemistry of Tetrapyrroles (Kadish K. M., Smith K. M. and Guilard R., eds), pp. 217356. World Scientific Publishing Co. Pte. Ltd., Singapore.
  • Smith A. and Morgan W. T. (1979) Haem transport to the liver by haemopexin. Receptor-mediated uptake with recycling of the protein. Biochem. J. 182, 4754.
  • Song W., Su H., Song S., Paudel H. K. and Schipper H. M. (2006) Over-expression of heme oxygenase-1 promotes oxidative mitochondrial damage in rat astroglia. J. Cell. Physiol. 206, 655663.
  • Song W., Zukor H., Lin S. H. et al. (2012) Schizophrenia-like features in transgenic mice overexpressing human HO-1 in the astrocytic compartment. J. Neurosci. 32, 1084110853.
  • Sung L., Morales P., Shibata M., Shipulina N. and Smith A. (2000). Defenses against extracellular heme-mediated oxidative damage: use of iron and copper chelators to investigate the role of redox active iron, copper and heme in the hemopexin heme transport system, in Iron Chelators: New Development Strategies (Badman D. G., Bergeron R. J. and Brittenham G. M., eds), pp. 6786. Saratoga Publishing Group, Sarotoga, FL.
  • Takahashi M., Dore S., Ferris C. D. et al. (2000) Amyloid precursor proteins inhibit heme oxygenase activity and augment neurotoxicity in Alzheimer's disease. Neuron 28, 461473.
  • Test S. T. and Weiss S. J. (1984) Quantitative and temporal characterization of the extracellular H2O2 pool generated by human neutrophils. J. Biol. Chem. 259, 399405.
  • Timmins G. S., Davies M. J., Song D. X. and Muller-Eberhard U. (1995) EPR studies on the effects of complexation of heme by hemopexin upon its reactions with organic peroxides. Free Radic. Res. 23, 559569.
  • Tong X. K., Nicolakakis N., Kocharyan A. and Hamel E. (2005) Vascular remodeling versus amyloid beta-induced oxidative stress in the cerebrovascular dysfunctions associated with Alzheimer's disease. J. Neurosci. 25, 1116511174.
  • Vanacore R., Eskew J., Morales P., Sung L. and Smith A. (2000) Role for copper in transient oxidation and nuclear translocation of MTF-1, but not of NFkB, by the hemopexin heme transport system. Antioxid. Redox Signal. 2, 739752.
  • Vermeulen Windsant I. C., de Wit N. C., Sertorio J. T., Beckers E. A., Tanus-Santos J. E., Jacobs M. J. and Buurman W. A. (2012) Blood transfusions increase circulating plasma free hemoglobin levels and plasma nitric oxide consumption: a prospective observational pilot study. Crit. Care 16, R95.
  • Vincent S. H., Grady R. W., Shaklai N., Snider J. M. and Muller-Eberhard U. (1988) The influence of heme-binding proteins in heme-catalyzed oxidations. Arch. Biochem. Biophys. 265, 539550.
  • Wallevik K. (1973) Reversible denaturation of human serum albumin by pH, temperature, and guanidine hydrochloride followed by optical rotation. J. Biol. Chem. 248, 26502655.
  • Weiss S. J. (1989) Tissue destruction by neutrophils. N. Engl. J. Med. 320, 365376.
  • Yoshinaga T., Sassa S. and Kappas A. (1982) The occurrence of molecular interactions among NADPH-cytochrome c reductase, heme oxygenase, and biliverdin reductase in heme degradation. J. Biol. Chem. 257, 77867793.
  • Zheng W., Xin N., Chi Z. H., Zhao B. L., Zhang J., Li J. Y. and Wang Z. Y. (2009) Divalent metal transporter 1 is involved in amyloid precursor protein processing and Abeta generation. FASEB J. 23, 42074217.